
Jan Kalyan Pharmaceuticals Private Limited
About Jan Kalyan Pharmaceuticals Private Limited
Data last updated:
Jan Kalyan Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the retail trade segment of the trading and commerce sector. It was incorporated on 18 January 2016.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2016PTC289665.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sangeeta Kapoor and Rohit Mohan Kapoor.
Its last annual general meeting (AGM) was held on 10 August 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at E – 78 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2017, the company reported a revenue of ₹27.72 Lakh. For the same year it recorded a net profit of ₹9,159 (net margin 0.3%) and EBITDA of ₹96,323 (EBITDA margin 3.5%).
Company details
Contact details
Jan Kalyan Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 78 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019
- IndustryTrading, Retailers, Retail Trading
To see the full contact details of Jan Kalyan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jan Kalyan Pharmaceuticals Private Limited
FY 2021 filings availableJan Kalyan Pharmaceuticals Private Limited reported revenue of ₹27.72 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹27.72 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹96,323 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹9,159 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.5% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Jan Kalyan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jan Kalyan Pharmaceuticals Private Limited
Jan Kalyan Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangeeta Kapoor | Director | 20 Mar 2017 | 9 Years 7 Months | As last reported |
| Rohit Mohan Kapoor | Director | 20 Mar 2017 | 9 Years 7 Months | As last reported |
Auditor
Jan Kalyan Pharmaceuticals Private Limited is audited by GUPTA GOEL & KHANNA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA GOEL & KHANNA | FY 2017 | 002528N |
Shareholding
The shareholding of Jan Kalyan Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jan Kalyan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jan Kalyan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jan Kalyan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jan Kalyan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jan Kalyan Pharmaceuticals Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Ishita Grotra ceased to be Director on 14 Apr 2017.
Frequently asked questions
Jan Kalyan Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Jan Kalyan Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in retailers, within the trading industry. It was incorporated on 18 January 2016 and is registered under CIN U51397DL2016PTC289665. The company has been struck off by the Registrar of Companies and is no longer operational.
Jan Kalyan Pharmaceuticals had 2 directors:
- Sangeeta Kapoor - Director
- Rohit Mohan Kapoor - Director
The CIN (Corporate Identification Number) of Jan Kalyan Pharmaceuticals is U51397DL2016PTC289665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Jan Kalyan Pharmaceuticals is at E – 78 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019.
Jan Kalyan Pharmaceuticals was incorporated on 18 January 2016. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Jan Kalyan Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 10 August 2021. Year-wise statements from FY 2016 are in the company report.
Jan Kalyan Pharmaceuticals operated in the trading industry, in the retailers segment. It worked in this industry before it was struck off.
Ishita Grotra ceased to be Director on 14 Apr 2017. Raghuvinder Kumar ceased to be Director on 14 Apr 2017. Rohit Mohan Kapoor was appointed as Director on 20 Mar 2017. Jan Kalyan Pharmaceuticals has 4 board changes on record in total.
The compliance status of Jan Kalyan Pharmaceuticals is compliant as of 08 September 2026.

